Identification of proteins differentially expressed upon neurotrophin receptor activation using DIGE and MALDI-MS

Activation of the neurotrophin receptor TrkA by its ligand NGF mediates growth inhibition and differentiation of neuroblastoma cells, whereas TrkB/BDNF signaling promotes proliferation and therapy resistance. Nonetheless, TrkA and TrkB exhibit a high level of sequence homology and use overlapping si...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Apostolov, O, Sitek, B, Pfeiffer, K, Stühler, K, Meyer, HE, Eggert, A, Schramm, A
Format: Tagungsbericht
Sprache:ger
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Activation of the neurotrophin receptor TrkA by its ligand NGF mediates growth inhibition and differentiation of neuroblastoma cells, whereas TrkB/BDNF signaling promotes proliferation and therapy resistance. Nonetheless, TrkA and TrkB exhibit a high level of sequence homology and use overlapping signaling pathways. To identify novel effector molecules contributing to the characteristic phenotypes of TrkA- and TrkB-expressing neuroblastoma cells, we analyzed global protein expression in neuroblastoma SY5Y cells stably transfected with TrkA or TrkB, and activated by their specific ligands in a time course from 0–24h. The recently introduced DIGE ( fluorescence 2-D difference gel electrophoresis ) system allowed reproducible identification of differentially expressed proteins between two samples in the same gel. In SY5Y-TrkA cells, we detected 8 proteins regulated upon NGF-induced receptor activation. Proteomic analysis of SY5Y-TrkB cells identified 23 proteins regulated upon BDNF-stimulation. Differentially expressed proteins were identified by MALDI-PMF/PFF mass spectrometry. Functional assignment revealed that the majority of identified proteins is involved in cytoskeleton organisation. Proteomics proved to be a promising tool to identify novel target proteins of Trk signaling in neuroblastoma cells. Supported by NGFN/BMBF and Deutsche Krebshilfe.
ISSN:0300-8630
1439-3824
DOI:10.1055/s-2004-828547